Press Releases

Date	Title	PDF Version
Feb 29, 2016	Alexion Employees Across the Globe Join Together to Support Rare Disease Day 2016
Feb 04, 2016	Alexion to Present at the Leerink Partners 5th Annual Global Healthcare Conference
Feb 03, 2016	Alexion Reports Fourth Quarter and Full Year 2015 Results and Provides Financial Guidance for 2016
Jan 20, 2016	Alexion Pharmaceuticals to Report Fourth Quarter and Full Year 2015 Results on Wednesday, February 3, 2016
Jan 15, 2016	Researchers to Present New Data at ENDO 2016 Advancing the Understanding of Strensiq® (asfotase alfa) in Infants, Children and Adult Patients with Hypophosphatasia (HPP)
Jan 04, 2016	Alexion to Present at the 34th Annual J.P. Morgan Healthcare Conference
Dec 10, 2015	Alexion Highlights Innovative Rare Disease Portfolio at Investor Day Meeting
Dec 10, 2015	Alexion to Highlight Innovative Rare Disease Portfolio at Investor Day Meeting
Dec 08, 2015	FDA Approves Kanuma™ (sebelipase alfa) for the Treatment of Patients with Lysosomal Acid Lipase Deficiency (LAL-D)
Dec 07, 2015	Data from the International Paroxysmal Nocturnal Hemoglobinuria (PNH) Registry Presented at ASH Annual Meeting Underscore Devastating Nature of PNH and Benefits of Soliris® (eculizumab) Treatment

Search